Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5536 | 59-06-3 |
None
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2A,ACVR2B,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,CSF1R,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,ITK,JAK1,JAK2,MAP2K6,MAP3K21,MAP3K7,MAPK7,MAPK9,MARK4,MET,MTOR,NTRK2,PAK4,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIK3CD,PIK3CG,PIM2,PLK1,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TTK,ULK1 | 52 | |||
| kinase-selectivity-class | AXL,DDR1,DYRK1B,GRK2,PDK4,STK33,TEK,TTK | 8 | |||
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D000981 | Antiprotozoal Agents |
| MeSH PA | D003049 | Coccidiostats |
None
| Species | Use | Relation |
|---|---|---|
| Chicken | Prevention of coccidiosis where severe exposure to coccidiosis from E acervulina | Indication |
| Chicken | Prevention of coccidiosis where severe exposure to coccidiosis from E maxima | Indication |
| Chicken | Prevention of coccidiosis where severe exposure to coccidiosis from E brunette | Indication |
| Product | Applicant | Ingredients |
|---|---|---|
| Amprol Hi-E, Amprol Plus | Huvepharma EOOD | 2 |
| Amprol HI-E Plus | Huvepharma EOOD | 3 |
| Amprol Plus and Aureomycin | Zoetis Inc. | 3 |
| Amprol HI-E & Bambermycins, Amprol HI-E / Flavomycin | Huvepharma EOOD | 3 |
| Baciferm / Amprol HI-E Premix | Zoetis Inc. | 3 |
| Albac / Amprol Hi-E | Zoetis Inc. | 3 |
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Neuraminidase | Enzyme | IC50 | 6.66 | CHEMBL |
| ID | Source |
|---|---|
| CHEBI:183844 | CHEBI |
| CHEMBL458769 | ChEMBL_ID |
| 96147003 | SNOMEDCT_US |
| C0015041 | UMLSCUI |
| D005011 | MESH_DESCRIPTOR_UI |
| D08916 | KEGG_DRUG |
| 6034 | PUBCHEM_CID |
| F4X3L6068O | UNII |
| 1314353 | RXNORM |
None